$GWAV

Greenwave Announces Receipt of Additional Delinquency Notice from Nasdaq

Greenwave Technology Solutions said Nasdaq issued an additional delinquency notice on May 21, 2026 for its delayed Q1 2026 Form 10-Q filing, citing noncompliance with Nasdaq Listing Rule 5250(c)(1). The company previously received a delinquency notice for its late 2025 Form 10-K. Nasdaq gives until June 22, 2026 to submit a compliance plan; trading remains on Nasdaq under “GWAV.”

Original reporting
Published May 27, 2026, 10:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 27, 2026, 10:30 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Greenwave Announces Receipt of Additional Delinquency Notice from Nasdaq — source image
Decision brief

The 30-second read

$GWAVBearishHigh
01

Why it matters

This adds another formal compliance strike and increases the probability of delisting unless the company executes on late filings and submits an acceptable regain-compliance plan by June 22, 2026.

02

Market read

Traders should focus on filing execution (late 10-Q/10-K) and Nasdaq’s acceptance of the compliance plan, as these are the primary catalysts for risk repricing.

03

What to watch

The release says there is no immediate effect on listing/trading; price may already reflect delinquency risk, so incremental impact depends on whether filings are imminent versus still delayed.

Relevance 9/10Timing: High: compliance plan deadline is June 22, 2026; additional risk persists until late 10-Q/10-K are filed and Nasdaq accepts the plan.

Background

Nasdaq issued an initial delinquency notice on April 22, 2026 for late 10-K; the company now reports a second notice tied to late Q1 10-Q, both under Rule 5250(c)(1).

Company-level read

Ticker impact

$GWAVBearishHigh confidence
Context

Greenwave received an additional Nasdaq delinquency notice for delayed Q1 10-Q filing, increasing delisting risk under Rule 5250(c)(1).

Expected impact

Near-term downside bias and elevated volatility as traders price worsening listing-risk; relief possible if late 10-Q/10-K filings land and Nasdaq accepts the plan.

Evidence & confidence

The notice explicitly states noncompliance due to delayed periodic filings and notes it could serve as an additional basis for delisting; the company also highlights no immediate trading halt but increased risk.

Market effects

Small-cap recycling/industrial services issuers with filing delays may see sector-wide multiple compression if investors generalize listing-risk.

Limited direct regional effect; impact is primarily on the issuer’s Nasdaq listing status rather than local fundamentals.

Low: this is a US exchange compliance event with limited cross-border fundamental linkage.

Counterpoint

If Greenwave quickly files the late 10-Q/10-K and Nasdaq accepts the compliance plan, the delisting overhang can fade faster than the market expects.

Key entities

  • Greenwave Technology Solutions, Inc.

    Nasdaq-listed metal recycler facing additional delinquency notice for delayed periodic SEC filings.

  • Nasdaq Stock Market LLC

    Listing authority issuing delinquency notices and evaluating compliance plans under Rule 5250(c)(1).

Related articles

$NVDAMed

Taiwan charges 9 over illegal AI server exports to China

Taiwan charged nine people, including one from Nvidia and two from Super Micro, for illegally exporting banned AI servers to China. The servers contained 'B300' GPUs, restricted from sale to China by US export controls. Nvidia stated it will cooperate with Taiwan's investigation. China is developing domestic chip alternatives due to US restrictions.

$TSLAHighAI 8/10

Tesla and Uber Won Robotaxi Permits—Why Citizens Kept Both Ratings Unchanged

Citizens analyst reiterated ratings on Tesla (Market Perform) and Uber (Market Outperform, $100 target). Nevada regulators granted permits for robotaxi services to Tesla, Uber, and Waymo. Tesla can operate up to 5,000 vehicles, while Uber and Waymo each have a 1,000-vehicle limit. Uber launched its first European autonomous robotaxi service in Zagreb. Investors await deployment progress and commercial scaling.

$LLYHighAI 9/10

FDA Approves Eli Lilly's Mounjaro To Reduce Cardiovascular Risk In Type 2 Diabetes

Eli Lilly's Mounjaro (tirzepatide) received FDA approval to reduce cardiovascular risk in type 2 diabetes patients. The approval follows positive results from the SURPASS-CVOT trial, showing an 8% lower rate of major adverse cardiovascular events compared to Trulicity. Mounjaro is the first GIP and GLP-1 receptor agonist with this indication, according to the company.

$RVMDHighAI 8/10

Revolution Medicines Won FDA Approval One Month After Filing. Analysts See $11.5 Billion in Peak Sales. Is the Stock Still a Buy After Skyrocketing More Than 5X?

Revolution Medicines (RVMD) received FDA approval for its pancreatic cancer drug, Rasonque, just weeks after filing. The drug showed significant efficacy in trials, leading to a 178% stock increase year-to-date. Analysts project peak sales of $11.5 billion, with potential for broader cancer treatment applications.

$METAMed

Meta Talking With States to Settle Landmark Lawsuit That Claims Facebook and Instagram Were Designed to Be Addictive to Kids: Report

Meta Platforms (META) is in settlement talks with states over a lawsuit alleging Facebook and Instagram were designed to be addictive to children. The trial involves 29 states accusing Meta of violating consumer protection and children's privacy laws. Meta denies the claims, stating social media addiction is not a recognized disorder. META shares closed at $570.05 on Tuesday, up 1.97%.